In addition, an anti-HSP90α monoclonal antibody 1G6-D7 had been developed to exhibit potent preventive efficacy against the tumor growth of native MDA-MB-231 cell grafts [26]. This evidence concerns the gene HSP90AA1 and neoplasm.